Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Siegfried Rhein is a distributor of hygiene and nutritional products, healing materials, and nutritional materials. They provide services that include antibiotics, analgesics, antidiabetics, antihypertensives, antitussives, dental treatments, antiallergic, respiratory, and urological. An online inquiry form is available on the company's website.

Mayoly Spindler is an independent French family-run pharmaceutical company which has been growing for several decades thanks to effective and recognized pharmaceutical products. They have extensive expertise in gastroenterology, rheumatology, ENT, general medicine and consumer health solutions. They have also diversified into dermocosmetics, with their Topicrem and Charlieu product lines. With their own production facilities, they are able to control our industrial developments.

Abbott Healthcare Products BV, part of Abbott Laboratories, is a company headquartered in Weesp, the Netherlands, that manufactures and distributes pharmaceuticals.

ASKA Pharmaceutical Co., Ltd. engages in the manufacture, sale, import, and export of pharmaceuticals, veterinary medicine, quasi-drugs, food, and medical devices. It operates through the Pharmaceutical Business and Other segments. The Pharmaceutical Business segment manufactures and sells medical drugs. The Other segment includes veterinary drugs, clinical testing, and medical devices. The company was founded by Yasohachi Yamaguchi on June 16, 1920 and is headquartered in Tokyo, Japan.

Alfasigma is a major group that has accepted an important challenge: finding solutions to cure the population each and every day. Alfasigma products are appreciated throughout the world. Technology, enthusiasm and specific expertise have ensured continuous growth and steady internationalization. Four graphics are presented below that illustrate the progress of the group in Italy and the world.

Dynogen is a privately held, neuroscience-based pharmaceutical company focused on genitourinary (GU) and gastrointestinal (GI) disorders. The company is utilizing its knowledge of the nexus between neurology and GU/GI disorders, as well as its predictive in vitro and in vivo pharmacology platforms to rapidly build a pipeline of development programs. Today, Dynogen has two ongoing development programs, one for overactive bladder (OAB) and another for irritable bowel syndrome (IBS). The company will advance its OAB program into Phase IIa trials and enter the clinic with its IBS program later this year.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Vetagro International SRL is a private company headquartered in Italy that leases real estate properties.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Wuxi Chengbo Technology Development Co., Ltd., established on 2008-08-27, Business scope includes inorganic non-metallic materials,Research on Refractories,to develop,technology transfer,Technical Services,technical consulting;Installation of intelligent building equipment,maintain,Sales;electronic product(Excluding satellite TV broadcasting ground receiving facilities and transmitters),computer software,hardware sales;Manufacture of graphite mucous fluid,processing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Rinat, which means "happiness" in Hebrew, was formed in 2001 when Genentech, a leader in the development of therapeutic antibodies, narrowed its focus and spun out its key neuroscience assets under a broad license to Rinat. Genentech invested significant R&D resources in support of these assets over 15 years, and Rinat is now building on them as the pioneer in developing and commercializing antibody drugs for the treatment of diseases and disorders of the nervous system.

Polaris Innovations Ltd., a subsidiary of Quarterhill, Inc., is a company headquartered in Dublin, Ireland. The firm functions as an investment holding company.

Part of AbbVie, Inc., AbbVie BV is a Dutch company. The firm manufactures pharmaceutical products.

Alfa Wassermann SpA manufactures pharmaceutical products. Its products include drugs for thromboembolic diseases, for the treatment and prophylaxis of deep-vein thrombosis, and for gastroenteric tract pathologies. The company was founded by Marino Golinelli on January 24, 1948 and is headquartered in Bologna, Italy.